We also demonstrated that dietary ω-3 PUFAs supplementation enhances the efficacy of immunotherapy in preclinical murine tumor models and that anti-PD-1 potently inhibits primary tumor growth in Fat-1 transgenic mice. The gene discussed is FAT1; the disease is neoplasm.